Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'device fda'
device fda published presentations and documents on DocSlides.
x0000x0000 USA IRB Policy and Procedurex0000x0000Page of
by elena
USA IRB Policy and Procedure...
Clinical/Surrogate Endpoints and Innovative Approaches for Catheter Ablation Studies
by SugarPlumFairy
FDA Perspective. Marco Cannella, PhD. Senior Lead ...
Human Factors in Digital Health
by Daredevil
Kimberly Kontson. , Biomedical Engineer, CDRH, FDA...
Importing & exporting ppe’s
by queenie
Disclaimer: The content of this webinar is for in...
Keeping Track of the Quacks Drug and Device Enforcement in the COVIDb
by blanko
10PDATEFall 2020Join our Author Happy Hour Discuss...
2011 American Association for Clinical Chemistry
by mackenzie
Page 1of 8The Journey to Regulation of Protein-Bas...
x0000x0000 xMCIxD 0 xMCIxD 0 Guidance for Industry2 xMCIxD
by smith
cdsnascderguid6019dftdoc 01/23/04 Draft 151 Not fo...
Guidance for Industry
by davies
and FDA Staff Class II Special Controls Guidance D...
From Cardiac Safety To SAFE PCI
by fullyshro
Mitchell W. . Krucoff. , MD, FACC. Professor, Medi...
1 Changing Smoking Habits
by envrrolex
2. Politics of Tobacco Regulation. FDA v. Brown &a...
Lab Oversight and Enforcement
by min-jolicoeur
Joyce E. Gresko. Alston & Bird LLP. (202) 239...
Regulatory weaknesses A report of the typist for the Regulation Subgroup
by phoebe-click
(i.e. no one has seen or approved this). Draft 07...
DRAFT FDASIA Committee Report
by briana-ranney
David W. Bates MD, . MSc. , Chair. 1. Committee M...
Importance of Instructions for Use: What is Changing
by test
Cynthia Spry, MA,MS,RN,CNOR(E),CSPDT. Independent...
Can I Make an App for That?
by mitsue-stanley
How FDA and HIPAA regulations apply to medical mo...
1 Changing Smoking Habits
by alexa-scheidler
2. Politics of Tobacco Regulation. FDA v. Brown &...
DRAFT-CONFIDENTIAL 1 FDA Initiative:
by stefany-barnette
Focus on Quality. June 11, . 2013. Francisco . Vi...
OFF LABEL MARKETING AND FREE SPEECH IN THE POST
by alexa-scheidler
CARONIA . AND . AMARIN . WORLD . Habib Nasrullah,...
HeartSine
by danika-pritchard
®. . Technologies COMPETITIVE LANDSCAPE. AVAILA...
OFF LABEL MARKETING AND FREE SPEECH IN THE POST
by mitsue-stanley
CARONIA . AND . AMARIN . WORLD . Habib Nasrullah,...
Future Directions in Symptom-Driven Consumer Applications
by danika-pritchard
Ed Daniels. mHealth Networking . Conference. Maki...
PD233: Design of Biomedical Devices and Systems (Lecture-5 Product Documentation)
by alec541
(Lecture-5 Product Documentation). Dr.. Manish Ar...
Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P
by ava
) Work Group. Co-Chairs: Paul Ashford, Executive...
Working with Investigational Assay Results
by phoebe
Week 6- Correlative Trials- A Case Based Approach....
Figure 11 Class I Recall Counts and Percentages FY 2003 FY 2012
by jones
11 0.0%1.0%2.0%3.0%4.0%5.0%6.0% Class I recall co...
Administration
by jordyn
U.S. Food & Drug 10903 New Hampshire Avenue Doc ID...
Section 5510K Summary A 0 As required by 21 CFR 80792Polyuretha
by freya
Classification Name: Colonoscope/Sigmoidoscope Acc...
OVO LASSIFICATION EQUEST FOR IRUITE OLD
by piper
IMITATIONS The ViruLite device is available as an ...
ScienceTranslationalMedicine
by naomi
www. .org 5 December 2012 Vol 4 Issue 163 163fs4...
The NIDA Standardized Research E-Cigarette (SREC)
by julia
Kevin Walton, Aidan Hampson. Division of Therapeut...
Advanced Research Billing: Devices
by jones
1. Medicare Coverage: 3 Part Process. Does the stu...
Vigilance on medical devices in hospitals workshop:
by bety
Adverse event notification, investigation and regu...
5 510K SUMMARY ptt This summary of safety and effectiveness is being s
by fiona
Intended Use / Indications for Use e dl tThe Medic...
KIDb15o510 K SUMMARY AUG 1 72010This summary of 5 10K safety and effec
by byrne
7 Discussion of Non-Clinical tests performed for D...
TOVA 90 Traditional
by natalie
510k ApplicationQbTestTest of Variables of Attenti...
510K SummarySubmitterJoseph Z Zdrok Associates7380 36TH CourtVero Bea
by cappi
510K Summary ContinuedUSEDescriptionThe Shanghai G...
Administration
by naomi
USFoodDrug10903 NewHampshireAvenueDoc ID 040170416...
V rcuje iz510k Summary of Safety and EffectivenessApplicant Name
by joanne
Collagen Matrix, Inc.510(k) Summary of Safety and ...
SEP tO 2 004 K o LqSECTION 16 510K SUMMARY1 DATE PREPAREDJune
by davis
diastolic blood pressure, and pulse rate (heart ra...
Administration
by desha
U.S. Food & Drug 10903 New Hampshire Avenue Doc ID...
Load More...